Bart has a strong track record of working with life sciences companies. He is a co-founder of Forbion Capital Partners, a leading European venture capital firm, where he invested in numerous healthcare companies and served as a non-executive director on the board of many portfolio companies. He also has operational experience, serving as CFO of Cellnovo Group SA, where he successfully led the company’s IPO on Euronext Paris. In his very first job at ABN AMRO bank, he initiated the life sciences team within ABN AMRO private equity. Bart holds various non-executive board positions in leading-edge life sciences companies.